Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT07406724 2026-02-12

HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma

Phase 2 Not yet recruiting

90 enrolled

Dermatologic

Melanoma

NCT07340619 2026-01-14

EPIBREAST

Phase 2 Not yet recruiting

51 enrolled

Dermatologic

Melanoma, Neoplasm Metastasis

NCT07040280 2025-06-27

Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma

Phase 2 Not yet recruiting

120 enrolled

Dermatologic

Melanoma, Skin Neoplasms

NCT06976021 2025-05-16

INTROSPECTION

Phase 2 Not yet recruiting

60 enrolled

BreastDermatologicGenitourinaryGynecologic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Melanoma, Triple Negative Breast Neoplasms

NCT06670300 2024-11-01

Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer

Phase 2 Not yet recruiting

20 enrolled

DermatologicGenitourinary

Kidney Neoplasms, Melanoma

NCT06500091 2024-07-15

TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors

Phase 2 Not yet recruiting

54 enrolled

DermatologicSarcoma

Melanoma, Sarcoma

NCT06470880 2024-06-24

DyNAMIc

Phase 2 Not yet recruiting

40 enrolled

Dermatologic

Melanoma

NCT06327698 2024-03-25

Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure

Phase 2 Not yet recruiting

30 enrolled

Dermatologic

Melanoma

NCT06183736 2023-12-27

CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency

Phase 2 Not yet recruiting

98 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT02498756 2015-07-15

Cytokine-induced Killer Study for Patients With Stage II Melanoma

Phase 2 Not yet recruiting

300 enrolled

Dermatologic

Melanoma

Clinical Trials

Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma

Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma

PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma

TRIUMPH-AM

GAPIMET

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma

EPIBREAST

Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma

INTROSPECTION

Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer

TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors

DyNAMIc

Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure

CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency

Cytokine-induced Killer Study for Patients With Stage II Melanoma